This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1995 Feb;208(2):144-9.

doi: 10.3181/00379727-208-43846c.

Tamoxifen for breast cancer prevention

V C Jordan¹

Affiliations

PMID: 7831346
DOI: 10.3181/00379727-208-43846c

Review

Tamoxifen for breast cancer prevention

V C Jordan. Proc Soc Exp Biol Med. 1995 Feb.

. 1995 Feb;208(2):144-9.

doi: 10.3181/00379727-208-43846c.

Author

V C Jordan¹

Affiliation

¹ Robert H. Lurie Cancer Center, Northwestern University Medical School, Chicago, Illinois 60611.

PMID: 7831346
DOI: 10.3181/00379727-208-43846c

No abstract available

PubMed Disclaimer

Similar articles

Scientific review of tamoxifen. Overview from a medical oncologist.
Carlson RW. Carlson RW. Semin Oncol. 1997 Feb;24(1 Suppl 1):S1-151-S1-7. Semin Oncol. 1997. PMID: 9045312 Review.
The case for clinical trials of tamoxifen for prevention of breast cancer.
Powles TJ. Powles TJ. Lancet. 1992 Nov 7;340(8828):1145-7. doi: 10.1016/0140-6736(92)93162-g. Lancet. 1992. PMID: 1359221 Clinical Trial. No abstract available.
Breast cancer prevention trials 'can re-start'.
Gavaghan H. Gavaghan H. Nature. 1994 Jun 16;369(6481):515. doi: 10.1038/369515a0. Nature. 1994. PMID: 8202147 No abstract available.
Tamoxifen. 'A big deal,' but a complex hand to play.
Marshall E. Marshall E. Science. 1998 Apr 10;280(5361):196. doi: 10.1126/science.280.5361.196b. Science. 1998. PMID: 9565527 No abstract available.
Tamoxifen for the prevention of breast cancer: no.
DeGregorio MW, Maenpaa JU, Wiebe VJ. DeGregorio MW, et al. Important Adv Oncol. 1995:175-85. Important Adv Oncol. 1995. PMID: 7672804 Review.

See all similar articles

Cited by

Tamoxifen inhibits acidification in cells independent of the estrogen receptor.
Altan N, Chen Y, Schindler M, Simon SM. Altan N, et al. Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4432-7. doi: 10.1073/pnas.96.8.4432. Proc Natl Acad Sci U S A. 1999. PMID: 10200279 Free PMC article.
Immunohistochemical Breast Cancer Profiling Among Iraqi Women: Molecular Subtype Classification, Clinicopathology Associations, and Treatment-Decision Making Tools: A Cross-Sectional Study.
Jumaah AS, Shaker RA, Al-Ali Z, Altoriah KMJ, Al-Quzweni A, Jumaah SS, Yasseen AA, McAllister KA, Al Shiblawi HJ. Jumaah AS, et al. Health Sci Rep. 2025 May 19;8(5):e70553. doi: 10.1002/hsr2.70553. eCollection 2025 May. Health Sci Rep. 2025. PMID: 40391262 Free PMC article.
Boosting immune surveillance by low-dose PI3K inhibitor facilitates early intervention of breast cancer.
Wang J, Zhang Y, Xiao Y, Yuan X, Li P, Wang X, Duan Y, Seewaldt VL, Yu D. Wang J, et al. Am J Cancer Res. 2021 May 15;11(5):2005-2024. eCollection 2021. Am J Cancer Res. 2021. PMID: 34094666 Free PMC article.
Tamoxifen in postmenopausal women a safety perspective.
Robinson E, Kimmick GG, Muss HB. Robinson E, et al. Drugs Aging. 1996 May;8(5):329-37. doi: 10.2165/00002512-199608050-00002. Drugs Aging. 1996. PMID: 8935395 Review.
Third annual William L. McGuire Memorial Lecture. "Studies on the estrogen receptor in breast cancer"--20 years as a target for the treatment and prevention of cancer.
Jordan VC. Jordan VC. Breast Cancer Res Treat. 1995;36(3):267-85. doi: 10.1007/BF00713399. Breast Cancer Res Treat. 1995. PMID: 8573710 Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information